background-splash

Tag: Autolus

Autolus received FDA approval for its innovative CAR-T oncology treatment in 2023, following positive phase two trial data. Founded by top-tier venture capitalists, the company has come a long way in just ten years, and its CAR-T therapies could reshape cancer treatment.

Never Miss a New Episode 💌

Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.

Watch & Subscribe